Is BioAdaptives Inc. (BDPT) a Buy, Sell, or Hold?
BioAdaptives Inc.
OTC:BDPT
$0.003 USD
$0.0 (233.33%)
- Volume
- 41.05M
- Average Volume
- 612.67K
- Market Capitalization
- $27.42K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.08
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.05
| Source | Headline |
|---|---|
|
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara's Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular repair-response biology The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular repair-response biology globenewswire.com - 2026-07-15 08:30:00 |
|
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments globenewswire.com - 2026-06-25 14:48:00 |
|
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
Perform. Repair. Repeat. — A stimulant-free, dual-phase platform built on the principle that cognitive excellence depends as much on what the brain does overnight as on what it achieves during the day. Perform. Repair. Repeat. — A stimulant-free, dual-phase platform built on the principle that cognitive excellence depends as much on what the brain does overnight as on what it achieves during the day. globenewswire.com - 2026-05-20 16:15:00 |
|
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep globenewswire.com - 2026-05-06 08:54:00 |
